about
The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis.Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection modelHost Protein Biomarkers Identify Active Tuberculosis in HIV Uninfected and Co-infected Individuals.The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection.Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway InhibitorsInhalation of recombinant adenovirus expressing granulysin protects mice infected with Mycobacterium tuberculosis.When Inhibitors Do Not Inhibit: Critical Evaluation of Rational Drug Design Targeting Chorismate Mutase fromMycobacterium tuberculosis
P2860
Q35829248-FA443D49-34D1-46DD-9E90-B75E71E72A3EQ35864589-3F8DB93A-C187-4418-B12F-199B4C334217Q36106333-38DC296B-EA54-40D7-A9A4-986C4FD08FA4Q36173327-196A5E6A-DE77-43A0-B27B-D9EBDCF90D3AQ36257295-6EA776EA-9C44-4903-AC76-9D21529602D1Q41105185-F1B1890E-F9C6-4A97-9F0C-A34972258655Q58378507-5374A456-57A9-43DD-804B-B4AF6849BDC7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immunity to TB and targets for immunotherapy.
@en
Immunity to TB and targets for immunotherapy.
@nl
type
label
Immunity to TB and targets for immunotherapy.
@en
Immunity to TB and targets for immunotherapy.
@nl
prefLabel
Immunity to TB and targets for immunotherapy.
@en
Immunity to TB and targets for immunotherapy.
@nl
P2860
P356
P1433
P1476
Immunity to TB and targets for immunotherapy.
@en
P2093
Mercedes Gonzalez-Juarrero
P2860
P304
P356
10.2217/IMT.11.168
P577
2012-02-01T00:00:00Z